These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12947218)

  • 1. Pharmacoinvasive management of acute coronary syndrome in the setting of percutaneous coronary intervention: evidence-based, site- and spectrum-of-care strategies for optimizing patient outcomes in NSTE-ACS.
    Kereiakes DJ; Tcheng J; Fry ET; Bhatt DL; Bosker G; Diez JG; Ferguson JJ; Levine GN; Schaer GL; Zidar J;
    J Invasive Cardiol; 2003 Sep; 15(9):536-53. PubMed ID: 12947218
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing unstable angina in high-risk patients.
    Chew DP; Moliterno DJ
    J Invasive Cardiol; 2002 Feb; 14 Suppl A():31A-48A. PubMed ID: 11847404
    [No Abstract]   [Full Text] [Related]  

  • 4. Interpretation of new treatment guidelines for non-ST-segment elevation acute coronary syndromes: "ischemia-guided" versus "early invasive" strategies.
    Boden WE
    Minerva Cardioangiol; 2003 Oct; 51(5):447-61. PubMed ID: 14551515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proper use of glycoprotein IIb/IIIa inhibitors in patients with non-sT elevation acute coronary syndromes undergoing coronary angiography: frankly, my dear, I don't give a damn.
    Bovenzi F; De Luca L
    J Cardiovasc Med (Hagerstown); 2006 Mar; 7(3):166-8. PubMed ID: 16645380
    [No Abstract]   [Full Text] [Related]  

  • 6. Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines.
    Antman EM
    Am Heart J; 2003 Oct; 146(4 Suppl):S18-22. PubMed ID: 14564302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Part II: risk stratification in patients with unstable angina and non-ST segment elevation myocardial infarction: evidence-based review.
    Doukky R; Calvin JE
    J Invasive Cardiol; 2002 May; 14(5):254-62. PubMed ID: 11983947
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III.
    Cohen M; Diez JE; Levine GN; Ferguson JJ; Morrow DA; Rao SV; Zidar JP; ;
    J Invasive Cardiol; 2007 Dec; 19(12):525-38; quiz 539-40. PubMed ID: 18180524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early cardiac catheterization is associated with lower mortality only among high-risk patients with ST- and non-ST-elevation acute coronary syndromes: observations from the OPUS-TIMI 16 trial.
    Cantor WJ; Goodman SG; Cannon CP; Murphy SA; Charlesworth A; Braunwauld E; Langer A
    Am Heart J; 2005 Feb; 149(2):275-83. PubMed ID: 15846265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.
    Mehta RH; Roe MT; Chen AY; Lytle BL; Pollack CV; Brindis RG; Smith SC; Harrington RA; Fintel D; Fraulo ES; Califf RM; Gibler WB; Ohman EM; Peterson ED
    Arch Intern Med; 2006 Oct; 166(18):2027-34. PubMed ID: 17030838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute coronary ischemic syndrome without ST elevation. Role of glycoprotein IIB/IIIA inhibitors and percutaneous coronary interventions].
    Peña Duque MA
    Arch Cardiol Mex; 2006; 76 Suppl 2():S249-51. PubMed ID: 17017111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoprotein IIb/IIIa receptor antagonists: are we ignoring the evidence.
    Singh S; Gopal AK; Bahl VK
    Indian Heart J; 2005; 57(3):201-9. PubMed ID: 16196176
    [No Abstract]   [Full Text] [Related]  

  • 13. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
    Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
    Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic strategies to improve the outcome of patients with diabetes mellitus and acute coronary syndrome].
    Cavallini C
    G Ital Cardiol (Rome); 2006 Apr; 7(4 Suppl 1):13S-20S. PubMed ID: 16749287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.
    Lenzen MJ; Boersma E; Bertrand ME; Maier W; Moris C; Piscione F; Sechtem U; Stahle E; Widimsky P; de Jaegere P; Scholte op Reimer WJ; Mercado N; Wijns W;
    Eur Heart J; 2005 Jun; 26(12):1169-79. PubMed ID: 15802360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative.
    Blomkalns AL; Chen AY; Hochman JS; Peterson ED; Trynosky K; Diercks DB; Brogan GX; Boden WE; Roe MT; Ohman EM; Gibler WB; Newby LK;
    J Am Coll Cardiol; 2005 Mar; 45(6):832-7. PubMed ID: 15766815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature.
    Bavry AA; Kumbhani DJ; Quiroz R; Ramchandani SR; Kenchaiah S; Antman EM
    Am J Cardiol; 2004 Apr; 93(7):830-5. PubMed ID: 15050484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
    Ferguson JJ; Wilson JM; Diez J
    Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tirofiban in acute coronary syndromes.
    Menozzi A; Merlini PA; Ardissino D
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):193-206. PubMed ID: 15853593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.